The content on this site is intended for healthcare professionals only
Dr Rocha Lima speaks with ecancertv at the Best of ASCO 2016 about developments in treating oesophageal and gastric cancer.
He discusses the negative results of adjuvant radiotherapy to treat cancer around the gastroesophageal junction, and the positive indication for a short course of FOLFOX to treat squamous oesophageal cancer compared to intermittent chemotherapy.
Prof Salah-Eddin Al-Batran introduced results of IMAB362 at this years ASCO conference, and discussed them with ecancer here.
ESMO 2024: Optimising the personalisation of prostate cancer treatment
GIST tumours and soft tissue sarcomas
Multiple myeloma in a resource constrained setting
OncoAlert Round Up for August 25th - 31st, 2023
OncoAlert Round Up for August 4th - 10th, 2023
First-line NALIRIFOX shows improvement in OS and PFS in metastatic pancreatic cancer
The current status of multiple myeloma diagnosis and treatment
Choosing Wisely in radiology Tanzania
CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC
